Condition
Mitral Valve Repair
Total Trials
7
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
Termination Rate
14.3%
1 terminated out of 7 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
14%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 1 (1)
P 2 (1)
P 3 (1)
Trial Status
Unknown2
Completed2
Not Yet Recruiting2
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT07434661Phase 3Not Yet Recruiting
Apixaban VS Warfarin in AF Pts First Three Months After Repair or BIO AVR MVR
NCT07314476Not Yet Recruiting
CardioLogical Interventions and Acute strOke Treatment sTudy
NCT04632641Not ApplicableCompleted
Suture Closure AFtEr VEIN Access for Cardiac Procedures (SAFE-VEIN) Trial
NCT05345730Completed
The Role of Left Atrial Fibrosis in Mitral Valve Repair Surgery (ALIVE Trial)
NCT03581656Not ApplicableUnknownPrimary
ChordArt System for Mitral Regurgitation
NCT01811537Phase 1UnknownPrimary
Safety and Efficacy Study of a New Device for Making Neochordae in Mitral Valve Repair
NCT00715845Phase 2Terminated
Carbon Dioxide Insufflation on Cerebral Microemboli
Showing all 7 trials